Boris Gorovits

Boris Gorovits

Pfizer Inc. - New York / United States
Others
AD Scientific Index ID: 4392122
-
person_outline Boris Gorovits's MOST POPULAR ARTICLES
1-) Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies Blood 103 (5), 1807-1814, 2004
2-) Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products Journal of immunological methods 333 (1-2), 1-9, 2008
3-) Bioanalysis of antibody–drug conjugates: american association of pharmaceutical scientists antibody–drug conjugate working group position paper Bioanalysis 5 (9), 997-1006, 2013
4-) Bioanalysis of antibody–drug conjugates: american association of pharmaceutical scientists antibody–drug conjugate working group position paperB Gorovits, SC Alley, S Bilic, B Booth, S Kaur, P Oldfield, S Purushothama, ...Bioanalysis 5 (9), 997-1006, 20131622013
5-) High hydrostatic pressure can reverse aggregation of protein folding intermediates and facilitate acquisition of native structureBM Gorovits, PM HorowitzBiochemistry 37 (17), 6132-6135, 19981361998